ABSTRACT: Background. We evaluated the use of intraoperative fluorescence guidance by enzymatically cleavable ratiometric activatable cell-penetrating peptide (RACPP PLGC(Me)AG ) containing Cy5 as a fluorescent donor and Cy7 as a fluorescent acceptor for salivary gland cancer surgery in a mouse model. Methods. Surgical resection of small parotid gland cancers in mice was performed with fluorescence guidance or white light (WL) imaging alone. Tumor identification accuracy, operating time, and tumor-free survival were compared. Results. RACPP guidance aided tumor detection (positive histology in 90% [27/30] vs 48% [15/31] for WL; p < .001). An approximate 25% ratiometric signal increase as the threshold to distinguish between tumor and adjacent tissue, yielded >90% detection sensitivity and specificity. Operating time was reduced by 54% (p < .001), and tumor-free survival was increased with RACPP guidance (p 5 .025).
INTRODUCTION
Currently, surgery is the primary treatment approach for most types of head and neck cancer. 1 Despite technical advancements, such as improvements in ultrasound technology and MRI, which provide an improved preoperative understanding of tumor location and characteristics, 2 the reported rate of positive or close surgical margins after head and neck cancer surgery remains considerable, ranging up to 43% depending on the location of the tumor, 3, 4 even with intraoperative histologic analysis of frozen sections. Surgeons have to rely on white light (WL) visualization and palpation to identify malignant tissue in an anatomic field where the immediate vicinity of vital structures, such as the cranial nerves, the external and internal carotid arteries, and the skull base, prohibits an overly generous resection to ensure the removal of all malignant tissue. Surgical margin status correlates strongly with local recurrence and overall prognosis for patients with head and neck cancer, 5, 6 emphasizing that there is a great need for tools to improve the intraoperative tumor identification and completeness of resection while preserving surrounding healthy tissue. 7 Molecularly targeted fluorescently labeled imaging probes could potentially fill this void. They provide real time guidance for the surgeon by increasing the dynamic range of visual cues to differentiate between tumor and nontumor tissue. Recently developed ratiometric activatable cell penetrating peptides (RACPP PLGC(Me)AG ) contain Cy5 as far red fluorescent donor and Cy7 as near-infrared fluorescent acceptor. 8 Until enzymatic cleavage of the peptide sequence PLGC(Me)AG by matrix metalloproteinases (MMPs) 2 and 9 occurs, Cy5 is quenched in favor of Cy7 emission. Increased MMP 2 and 9 activity has been shown to be associated with many different types of cancer and we have previously shown tumor labeling in animal models of melanoma and breast cancer. 9 MMP 2 and 9 are also overexpressed in the microenvironment of human head and neck cancer variants, 10 and MMP2/9 mRNA has recently been reported to be increased in head and neck squamous cell carcinoma specimens from The Cancer Genome Atlas cohort compared to paired control normal tissue, 11 emphasizing the relevance of this technology in head and neck squamous cell carcinoma.
Upon cleavage by MMP 2 and 9, tissue retention of the Cy5 containing fragment occurs, while uncleaved peptides continue to emit fluorescence signal at Cy7 wavelength. Cancer to background contrast is generated based on the ratio of the 2 fluorescence emissions (Cy5/Cy7). Compared to single fluorophore probes, the ratiometric approach is relatively independent of interindividual differences in pharmacokinetics, such as total probe uptake and washout, as well as thresholding. The rapidity of ratiometric change is particularly useful for surgical application of RACPP PLGC(Me)AG . Malignant tissue (including primary tumors, distant metastases, or lymph nodes) to background contrast is generated within 1 to 2 hours after systemic application, allowing for a real-time assessment of tumor margins and lymph node status.
In this study, we evaluated whether RACPP PLGC(Me)AG could improve the intraoperative identification and removal of head and neck tumors in a mouse model of parotid gland cancer. The parotid gland is a particularly delicate surgical field because of the immediate proximity of the facial nerve, making additional intraoperative guidance highly desirable to avoid over-resection while at the same ensuring tumor-free surgical margins. We compared RACPPguided parotid gland cancer surgeries to procedures performed under WL alone and quantified operating time, sensitivity, and specificity of the probe as well as long-term postoperative tumor-free survival. We also determined the ratiometric threshold for RACPP to allow for optimal tumor removal without over-resection of normal tissue.
MATERIALS AND METHODS

Animals
Seventy female Swiss-Webster mice (Jackson Laboratories, Bar Harbor, ME) were used in this study. All animal studies were approved by the UCSD Institutional Animal Care and Use Committee (protocol number S05536). Sixty-one mice were included in the tumor removal study, 9 mice were used to establish the tumor model and for additional confocal microscopic imaging.
Establishment of the tumor model
To assess the kinetics of tumor growth after orthotopic injection of murine salivary gland cancer cells (SCA-9 clone 15, ATCC CRL-1734, American Type Culture Collection) and to determine the optimal cell injection dose to create small (1-2 mm) parotid gland cancers after 14 days, 2.5 3 10 5 , 5 3 10 5 , 1 3 10 6 , or 2 3 10 6 cells were injected into the right parotid glands of 8 syngeneic immune competent mice (n 5 2 per cell amount). Animals were anesthetized with ketamine (50 mg/kg) and midazolam (1 mg/kg) for the procedure, and hair on the right side of the face was removed using depilatory cream (Nair; Church and Dwight, Ewing, NJ). Tumor growth patterns were observed by daily observation and palpation as well as by autopsy and histologic analysis after euthanization of the mice 14 days after cell injection.
Molecular imaging probe
The RACPP was synthesized, as previously described. 12 In brief, H 2 N-e 9 -c(SS-tBu)o-PLGC(Me)AG-r 9 -c-CONH 2 was reacted with Cy5-maleimide, subsequently treated with triethylphosphine to deprotect the tert-butylthio group, and then purified using high-performance liquid chromatography. The purified compound was then reacted with m-dPEG 12 -MAL (Quanta Biodesign). After completion of the reaction, Cy7 mono NHS ester (Cy7-NHS, GE Health Sciences) was added to get RACPP (Cy7-NH-e 9 -c(peg 12 )-oPLGC(Me)AG-r 9 -c(Cy5)). Then, the final compound was purified using C-18 reverse-phase highperformance liquid chromatography.
Intraoperative fluorescent optical imaging
Fluorescent intraoperative optical imaging was performed with a modified Olympus OV100 small animal imaging system (Cy5: 640 nm excitation/685 nm emission; Cy7 762 nm excitation/785 nm emission).
Survival surgery
Sixty-one Swiss-Webster mice with orthotopic salivary gland tumors generated by percutaneous injection of murine salivary gland cancer cells into the right parotid gland were included in the study. Before the surgical procedure, animals were either placed into the RACPP guidance arm (n 5 30) or the control group on which surgeries were performed with WL visualization alone (n 5 31).
Animals that were in the RACPP arm were briefly anesthetized with inhalational isoflurane and intravenously injected with RACPP 2 hours before the beginning of the tumor removal surgery to allow for a sufficient MMP cleavage-induced accumulation in tumor and washout of nonspecific binding from nontumor tissue.
For the surgeries, animals were injected with ketamine (150 mg/kg) and xylazine (10 mg/kg). After facial hair removal with depilatory cream, a 2 cm infraauricular skin incision was made and the skin was retracted. Depending on their respective group allocation, salivary gland tumor identification was then attempted under WL or with RACPP guidance by surgically exploring the parotid gland and the surrounding infraauricular region. The time from skin incision to tumor exposure was quantified for both groups. In the WL group, tissue that seemed most likely to be malignant in the parotid gland or the immediate vicinity of the gland was removed. In the RACPP guided group, fluorescently labeled foci in the same anatomic region were removed. All tissue was carefully excised in an attempt to preserve crucial anatomic structures, such as the facial nerve or the external jugular vein and its branches. However, if the tumor had invaded those tissues, they were removed to ensure a maximal completeness of resection. Heat-cautery was used as needed to achieve hemostasis. After completion of tumor resection, the skin was closed in a single layer. All animals were monitored daily for 5 days postoperatively to ensure adequate recovery from the surgical procedure.
Tumor-free survival
After the initial 5-day postoperative observation period, all mice were monitored by research personnel blinded to the experimental condition once every 4 weeks for potential tumor recurrence by clinical inspection and manual palpation under a brief inhalational isoflurane anesthesia. If a deterioration in animal health was indicated by substantial weight loss, obvious discomfort, or abnormal behavior, animals were euthanized and removed from the study. For every clinical inspection, facial hair was removed with depilatory cream. If tumors were palpable or visible and the tumor diameter exceeded 5 mm, animals were euthanized and the respective postoperative observation timepoint was considered the endpoint of tumor-free survival. Animals in which tumors smaller than 5 mm in diameter were clinically observed were further monitored. If the clinical tumor detection could be confirmed at the following inspection timepoints, the timepoint of first detection was considered the endpoint of tumor-free survival.
The final postoperative monitoring timepoint was 24 weeks after tumor removal surgery. At this point, all remaining mice were euthanized. To definitely determine the presence or absence of tumor, as previously assessed by the clinical inspection, tissue samples were collected from the parotid gland region for histologic analysis. The majority of mice underwent a limited tissue collection procedure during which approximately 1 3 1 3 1 mm 3 biopsies were collected from the surgical field. This limited collection yielded inconclusive results, largely because of insufficient tissue. Consequently, the remaining mice (n 5 18 [10 RACPP, 8 controls]) underwent an extensive tissue collection procedure, including the tissue surrounding the parotid gland, such as the infraauricular fat pad, connective tissue, as well as the lymph nodes. On average, 4 samples (one from each quadrant of the surgical field) of approximately 3 3 3 3 3 mm 3 were excised from the parotid gland region. Thus, the entire former surgical field could be histologically analyzed for potential tumor recurrence.
Histologic analysis
Tissue that was excised during the initial tumor removal surgery and during the postoperative follow-up analysis was immediately embedded in optimum tissue cutting formulation (Tissue Tek; Thermo Fisher Scientific, Waltham, MA) and frozen. Multiple cryosections (8 mm) were obtained from every sample and histologic analysis was conducted using hematoxylin-eosin staining. A board certified pathologist blinded to the experimental conditions performed all histologic analysis.
Microscopic tumor imaging
To further characterize fluorescent staining of malignant cells and their environment, additional in vivo confocal imaging was performed with a Nikon A1 upright confocal microscope (see Figure 1 ).
Determination of ratiometric threshold
A receiver operator characteristic (ROC) analysis was performed to determine the accuracy of the ratiometric imaging probe and to identify an optimal threshold for the discrimination between tumor and healthy tissue. Cy5/ Cy7 ratios were measured on images acquired during surgery from tumor tissue (n 5 25), as well as tumor-free adjacent tissue (n 5 34). Measurements were performed on ratiometric Cy5/Cy7 images acquired intraoperatively from mice that had later undergone an extensive tissue collection procedure followed by histologic analysis to confirm the presence or absence of tumor. Cy5/Cy7 intensity ratios were measured in Image J by hand selecting regions of interest that had been histologically confirmed to be a tumor as well as from immediately adjacent tissue in quadrants around the tumor confirmed to be tumor free. The mean pixel intensity values were measured. Cy5/Cy7 ratios were in all cases normalized to the Cy5/ Cy7 background signal, which was measured from skin tissue located outside the surgical bed.
Data analysis
Statistical data analysis was performed using SigmaPlot software (Systat, San Jose, CA). An unpaired t test was used to compare time to tumor exposure, Fisher's exact test was utilized to compare binary operative and postoperative histology results. An ROC analysis was conducted to analyze sensitivity and specificity of RACPP. The differences in tumor-free survival assessed by clinical observation were compared with a log-rank test; Kaplan-Meier curves were plotted for postoperative tumor-free survival times. To accommodate possible errors in clinical assessment of tumor occurrence status in some mice, a simulation study was performed based on the observed error rates.
RESULTS
Establishment of tumor model
Injection of 1 3 10 6 salivary gland cancer cells into the right parotid gland region led to the development of tumors with a diameter of 1 to 2 mm after 14 days, as confirmed by autopsy and histologic analysis. This tumor size was determined to be suitable for the purpose of this study in which we attempted to evaluate the value of fluorescence guidance for the surgery of small salivary gland tumors. In order to simulate spontaneous tumor behavior, the malignant cells were injected through the skin without direct visualization of the gland in order to produce variability in the location of the cancer. This technique resulted in some tumors being located directly in the parotid gland, while others grew deeper within the masseter muscle or the infraauricular fat pad. A single surgeon blinded to the exact location of tumor injection performed all surgical resections.
Time to intraoperative tumor exposure
The operative time after skin incision to tumor exposure was quantified for both experimental groups. Tumor identification was significantly faster with ratiometric fluorescence imaging compared to WL alone (p < .001; Table 1 ). With RACPP guidance, foci with high ratiometric values detected and surgically exposed in 5.1 6 1.8 minutes (n 5 30). Under WL, the infraauricular region had to be extensively explored surgically and potentially malignant foci were exposed on average after 11.2 6 2.5 minutes (n 5 31).
Intraoperative detection of malignant tissue
Intraoperative guidance with RACPP significantly aided tumor identification compared to WL alone. Twentyseven of thirty (90%) fluorescent foci excised were histologically positive for cancer, compared to 15 of 31 (48%) suspicious foci excised from the WL group (p < .001; Table 1 ; Figures 2 and 3) . Thus, the positive predictive value of the imaging probe was 90.0%, compared to 48.4% for WL. Sensitivity and specificity of the RACPP compared to WL in this experiment were calculated based on histology of tissue samples excised during the surgical procedure, which were assumed to be positive for tumor (test positive condition), as well as samples excised from the surgical bed postoperatively, which intraoperatively had been considered tumor-free (test negative condition). With RACPP guidance, 27 of 29 samples taken during the surgical procedure were correctly identified as tumor positive compared to 15 of 19 under WL. With RACPP guidance, 3 of 41 samples (7.31%) from the surgical bed were false-positives, compared to 16 of 44 (36.4%) with WL. Sensitivity for RACPP was 93.1% (n 5 27/29) versus 79.0% for WL (n 5 15/19) and specificity was 92.7% for RACPP (n 5 38/41) versus 63.6% for WL (n 5 28/44; Figure 4A ).
Based on the ROC analysis ( Figure 4B ), RACPP showed very high accuracy for discriminating between tumor and adjacent nontumor tissue (normal parotid gland, adipose tissue, connective tissue, muscle; area under the curve 5 0.98 6 0.02; p < .0001). A ratiometric threshold in the range of 1.2 and 1.3 to discriminate between tumor and healthy tissue yielded the best sensitivity and specificity values. For example, a 1.265-fold increase in Cy5/Cy7 ratio between tumor and background resulted in 92.0% sensitivity and 91.2% specificity for tumor detection. This range of ratiometric change in fluorescence between tumor (Cy5/Cy7)/background (Cy5/ Cy7) is consistent with a previous report of RACPP performance. 12 
Tumor-free survival
Of the 61 mice on which tumor removal surgery was performed, 6 mice (2 in the RACPP group, 4 in the WL group) died during the initial postoperative observation period or over the course of the follow-up period, most likely because of surgical complications, and these were excluded from further analysis.
Follow-up by clinical inspection and palpation
Fifty-five mice (28 in the RACPP group, 27 in the WL group) mice were assessed by clinical inspection and palpation with monthly follow-up. The postoperative assessment indicated that tumor-free survival was significantly FIGURE 1. (A) Macroscopic ratiometric image of a large parotid gland tumor (white stippled outline) imaged after ratiometric activatable cellpenetrating peptide (RACPP) injection. Red pseudocolor indicates high Cy5/Cy7 ratio, whereas blue/green color indicates low Cy5/Cy7 ratio. The overlying skin has been retracted from the tumor and shows high ratio because of cancer invasion (white arrows). Scale bar: 5 mm. (B) Area of the anterior tumor border (white asterisk in A) imaged at higher magnification with confocal microscopy. Individual cells are labeled with higher Cy5/Cy7 ratio than others and can be distinguished from fat vacuoles (white asterisks in B) and healthy surrounding tissue (white stippled outline) around the tumor. Scale bar: 100 mm (original magnification 325). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] increased (p 5 .025) when mice had received tumor removal surgery aided by fluorescence guidance rather than WL surgery ( Figure 5A ). Over the course of the 6-month follow-up survival period, 4 mice (3 in the RACPP group and 1 in the WL group) developed tumors exceeding 5 mm in diameter and were euthanized; time to tumor recurrence was noted for the survival analysis with time of death the day of euthanization. The remaining mice were followed to 24 weeks after surgery, at which time they were euthanized and tissue obtained from the surgical bed was sent for histologic analyses.
Histologic analysis
The final histologic analysis after 6 months included tissue samples from 51 mice. The results from the initial limited tissue collection procedure (n 5 33) were inconclusive, largely because of insufficient tissue samples, showing detection of tumor in only 2 of 33 mice (6%). A more extensive tissue collection procedure (3 3 3 3 3 mm sample from each surgical quadrant) was performed on the remaining 18 mice (10 in the RACPP group, 8 in the controls group). Histologic results from these mice showed that 20% of the mice (2 of 10 mice) that had undergone RACPP-guided surgery were positive for tumors, compared to 50% of mice (4 of 8 mice) from the WL group. In 83% of cases (15 of 18 mice), the histologic findings confirmed the presence or absence of tumors as assessed by the clinical follow-up. Two mice (1 in the RACPP group and 1 in the WL group), which had clinically shown signs of a parotid mass did not have histologically confirmed cancer, 1 mouse (RACPP group) showed positive histologic evidence of cancer despite the absence of any clinically detectable mass. An analysis of tumor-free survival for the subgroup of 18 mice ( Figure  5B ), taking into account the clinical follow-up findings, and corrected according to the final histology results showed that RACPP-guided surgery tended to increase tumor-free survival and the 2 curves were well separated, but did not attain statistical significance (p 5 .19), perhaps because of the limited sample size. After correcting tumor recurrence times and statuses for these 3 mice, using the whole data set of 55 mice, the RACPP group still had a significantly longer tumor-free survival time than the control group (p 5 .04).
We conducted a sensitivity analysis to address the concern that 33 mice did not go through the intensive histologic examination, which had to be considered the gold standard to determine potential presence of tumor, leaving some uncertainty regarding tumor recurrence status. Among these mice there were 16 recurrences and 17 nonrecurrences based on clinical assessment. We thus performed a simulation study to assess the robustness of the treatment effect after accommodating possible response assessment errors. From the 18 mice with certain tumor statuses, we estimated that the probability of mistreating tumor nonrecurrence as recurrence was 28% (2 of 7); whereas the probability of mistreating tumor recurrence as nonrecurrence was 9.1% (1 of 11). Using these rates, we randomly imputed 4 of 16 observed recurrences to be true nonrecurrences and set their survival times to be 24 weeks; we also randomly imputed 2 of 17 the observed nonrecurrences to be true recurrences and randomly chose their event times from the set of 4, 8, 12, 16, 20 , and 24 weeks. We then combined these 33 mice with imputed recurrence status together with the rest of the 23 mice with certain event statuses. A p value was generated from this combined full dataset. We repeated this process 1000 times and summarized p values. The median of these p values was .096 with interquartiles ranging from 0.03 to 0.13. Thus, the simulation analysis showed that the RACPP group was at least marginally significantly associated with longer tumor-free survival, even accounting for possible estimated ascertainment error.
DISCUSSION
The utilization of fluorescently labeled intraoperative molecular markers is still in the early stages of development but could substantially improve oncologic surgery. 8, 13 Fluorescent dyes and fluorescently labeled targeted probes have been shown to improve surgical results in human brain, liver, and ovarian cancer surgery. [14] [15] [16] [17] For head and neck cancer surgery, no intraoperative fluorescence guidance tools are in routine clinical use, but recent studies in animal models have suggested that fluorescence guidance can potentially be a valuable addition to existing treatment modalities. [18] [19] [20] A variety of potential tumor-specific targets for intraoperative optical imaging are evolving, 21 and for the intraoperative identification of head and neck cancers prior investigative approaches have focused primarily on antibody-based probes. [22] [23] [24] [25] While antibody-targeted approaches depend on adequate expression levels of highly specific markers, RACPP PLGC(Me)AG offers a more comprehensive approach because it is enzymatically activated by MMPs 2 and 9, which are associated with cancer invasion and metastasis across many different types of cancer. [26] [27] [28] [29] Prior promising results in models of melanoma and breast cancer prompted us to assess the value intraoperative RACPP PLGC(Me)AG guidance for head and neck cancer surgery. Elevated MMP levels in the tumor microenvironment of head and neck cancers are a result of overexpression by multiple tumor-associated cell types, including immune cells, 30 reinforcing the necessity to perform the experiments in immune competent mice; our particular orthotopic model also allowed for a long-term postoperative follow-up in this study.
Our results show that RACPP PLGC(Me)AG fluorescently labels small salivary gland cancers in mice with high specificity and sensitivity, hereby significantly aiding their intraoperative detection and surgical removal. The high specificity for labeling tumors 2 hours after probe injection emphasizes the value of the ratiometric imaging approach to minimize nonspecific signal generation, one of the key limiting factors of optical imaging approaches. 31, 32 Tumors generated in this study were only 1 to 2 mm in diameter at the time of surgery and not detectable clinically. Without fluorescence guidance, only 48% of the small lesions could be located compared to 90% in the RACPP-guided group where the surgeon was guided to their location after skin incision. Our results suggest that intraoperative fluorescence guidance could be particularly valuable for the detection of clinically occult tumors of the head and neck. Especially when searching for an unknown primary in patients with metastatic head and neck cancer, diagnostic surgeries are required and large amounts of tissue have to be resected to yield positive results. 33, 34 In this study, an accurate detection and resection of small tumors was facilitated by intraoperative fluorescence guidance and time to tumor exposure was reduced by over 50%. Reducing operating time not only lowers associated cost but potentially favorably impacts postoperative patient morbidity, which has been shown to correlate with the extent of parotid gland surgery. 35 It should be noted no preoperative ultrasound or MRI was performed in this study, although they are part of today's clinical staging process for salivary gland cancers. Both imaging modalities could have potentially provided additional preoperative information in this particular model, offering high sensitivity and spatial resolution. 36, 37 Preoperative imaging, however, cannot provide the same level of guidance for the surgeon as real time imaging during the surgical resection as the orientation provided preoperatively is often lost after initial tissue dissection, particularly complicating the identification of small tumors.
Although the field of fluorescence-guided surgery is gaining momentum with development of novel probes and instrumentation, one fundamental question remaining is how to determine the threshold for optimal tumor removal without over-resection of normal tissue. In this study, we leveraged the ratiometric nature of RACPP to address this issue by ROC, a commonly used tool to assess detection accuracy levels for imaging tools in cancer surgery. [38] [39] [40] The use of RACPP improved the intraoperative detection of very small tumors compared to WL with >90% sensitivity and specificity, and these levels corresponded to the detection accuracy for approximately a 25% ratiometric signal increase as the discrimination threshold between malignant and healthy tissue, as determined by postoperative ROC analysis. By selecting a certain ratiometric signal threshold, sensitivity or specificity can be emphasized more strongly, depending on the preferred surgical outcome. We believe that this finding presents a significant advance in the field of molecular surgical navigation as it demonstrates proof of concept using ratiometric fluorescence to determine a threshold for the accuracy of tumor detection. In clinical practice, selection of a ratiometric threshold yielding high sensitivity could help to ensure tumor-free surgical margins while still allowing for an accurate resection without sacrificing healthy tissue. In this study, the long-term (6 months) follow-up suggested increased tumor-free survival for mice that had been operated with RACPP guidance compared to the mice that were operated on using WL alone, indicating that RACPP guidance enabled a complete tumor resection (ie, clear surgical margins in the majority of mice).
It should be noted that the final histologic analysis performed in this study to confirm our clinical findings demonstrated some ascertainment errors. The extensive histologic analysis performed on a subgroup of mice confirmed the presence or absence of tumor as assessed by the clinical follow-up in 83% of cases and revealed that recurring or progressing tumors were mostly <3 mm in diameter and sometimes located deep in the tissue surrounding the parotid gland as well as adjacent lymph nodes. The small size of tumors detected by histologic analysis after the 6-month follow-up period also suggests that the findings of the clinical postoperative assessment can most likely not be attributed to the manual or visual detection of tumors in all cases. However, the extensive histologic analysis showed that mice that had tumors regularly also had grossly enlarged cervical lymph nodes. We therefore hypothesize that these may have been manually detected during the clinical follow-up period, indirectly but correctly indicating tumor prevalence. We note, however, that clinical assessment was blinded as to group status, supporting our findings of a significant difference. In addition, extensive and conservative simulation results incorporating the uncertainty of assessment generally supported our findings.
In conclusion, we show that RACPP is a promising optical molecular imaging probe with very sensitive and specific intraoperative tumor visualization. The broad applicability for many types of cancer should benefit future clinical translation of this imaging probe. In head and neck cancer surgery in particular, the high accuracy in labeling small tumors can be very valuable to aid identification and resection while reducing operating time and limiting damage to surrounding important structures. Postoperative follow-up data suggests that RACPP may increase tumor-free survival after surgery by facilitating complete tumor resection.
